1. Home
  2. IRIX vs DARE Comparison

IRIX vs DARE Comparison

Compare IRIX & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.71

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.72

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
DARE
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
13.9M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
IRIX
DARE
Price
$0.71
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
95.1K
698.6K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
51.85
N/A
EPS
N/A
N/A
Revenue
$41,593,000.00
$2,807,885.00
Revenue This Year
$3.07
$2,115.12
Revenue Next Year
$6.66
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.73
52 Week High
$1.65
$3.78

Technical Indicators

Market Signals
Indicator
IRIX
DARE
Relative Strength Index (RSI) 30.29 26.11
Support Level N/A N/A
Resistance Level $1.16 $1.68
Average True Range (ATR) 0.05 0.13
MACD -0.01 -0.01
Stochastic Oscillator 4.14 1.14

Price Performance

Historical Comparison
IRIX
DARE

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: